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Abstract
Tattooing has long been practised in various societies all around the world and is becoming increasingly common and widespread
in the West. Tattoo ink suspensions unquestionably contain pigments composed of nanoparticles, i.e., particles of sub-100 nm
dimensions. It is widely acknowledged that nanoparticles have higher levels of chemical activity than their larger particle equiva-
lents. However, assessment of the toxicity of tattoo inks has been the subject of little research and ink manufacturers are not obliged
to disclose the exact composition of their products. This study examines tattoo ink particles in two fundamental skin components at
the nanometre level. We use atomic force microscopy and light microscopy to examine cryosections of tattooed skin, exploring the
collagen fibril networks in the dermis that contain ink nanoparticles. Further, we culture fibroblasts in diluted tattoo ink to explore
both the immediate impact of ink pigment on cell viability and also to observe the interaction between particles and the cells.
Introduction
The act of tattooing has been practised for many centuries in a
number of countries including Japan, China, New Zealand as
well as in regions of North Africa. The oldest recorded human
tattoo was found on a well-preserved natural mummy from
about 5,300 years ago, found in the Ötztal Alps in Italy, close to
the border with Austria [1]. These ancient tattoos do not appear
to have had decorative importance but may had have had some
medical/therapeutic relevance, some appear to be close to tradi-
tional acupuncture points [2]. Today, tattooing is becoming
increasingly popular across several sections of society, with
increasing numbers of tattoo parlours opening for business.
However, despite this striking cultural shift we know very little
about the biochemical reactivity of ink particles with skin cells
and tissues (including some of the key constituent components,
e.g., fibroblasts and associated collagen fibrillar networks).
The tattooing process involves inserting ink pigment of the
desired colour into the dermis layer of the skin. This is carried
out by first dipping a needled tattoo instrument into the
coloured ink before applying to the skin. The oscillating ink-
coated needle punctures the skin in the range of 100 times per
second, depositing the ink pigments 1.5 to 2 mm below the skin
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surface. Thus, the needle penetrates the skin through the
epidermis and into the papillary layer of the dermis, where the
ink particles accumulate. As with any type of trauma to the
dermis, the first response of the body is to stop the resultant
bleeding to form a clot. Then the skin tissue swells (edema) fol-
lowed by a migration of immune system cells to the wound site
(neutrophils and macrophages) in order to phagocytose foreign
substances, cell debris and microbes. Any damaged collagen in
the wounded papillary dermis is then repaired through the
action of fibroblasts, ultimately laying down scar tissue. Over
long periods of time the tattoo ink particles can be found to
gradually move to the deeper dermis (i.e., reticular dermis),
which gives the tattoo a faded and blurred appearance. Impor-
tantly, after tattoo ink insertion associated pigment particles can
be found to leave the skin via its vasculature and enter the
lymphatic system (nodes) [3].
Tattoo inks are commonly made up of a mixture of small
organic pigments, water and isopropyl alcohol. Surprisingly,
manufacturers of tattoo ink are not compelled to reveal the
precise ingredients or chemical composition of their ink prod-
ucts despite their potential systemic absorption. Black inks are
commonly made from soot (carbon black) particles. Tattoo inks
can contain polycyclic aromatic hydrocarbons (PAHs) at a
range of concentrations, which are reported to be carcinogenic,
mutagenic and could pose other health risks to the skin [4].
Further, it was recently reported that tattooed young individuals
can exhibit adverse reactions, especially with black or red ink
tattoos, including photosensitivity, skin elevation and itching
[5].
Nanoparticle research is currently receiving a great deal of
interest due to its potential applications in biophysics, medicine,
optics and electronics. A particle is generally considered to be a
nanoparticle if it has dimensions below about 100 nm. For
example, researchers in cancer nanotechnology are exploring
methodologies to utilise functionalised quantum dots and
nanocrystals to target specific tumour antigens [6]. Other
medical research on nanoparticles includes the formation of a
network of nanoparticles with an insulin core that can regulate
and control normal blood sugar level [7]. However, despite
considerable progress in nanoscience, it is often argued that the
ethical and socio-legal implications of nanoparticles have been
neglected [8]. Potential hazards of nanoparticles exist due to
their high surface to volume ratio, which can make them very
reactive [9], and their small size that can enable them to pass
through cell membranes. The toxicity or biocompatibility of
nanoparticles is an extremely important consideration for many
of the aforementioned proposed applications. In particular
carbon nanotubes, commonly used in applications such as drug
delivery [10] and directed growth of neuron cells [11], have
been shown to exhibit cytotoxicity potential [12], although
carbon nanotube toxicity differs according to the production
method used [13]. Moreover, the carbon black nanoparticles
found in tattoo ink have safety profiles comparable to multi-
walled carbon nanotubes [14]. Thus, there is a need to more
accurately assess how tattoo ink particles directly interface with
human cells and tissues. Atomic force microscopy (AFM) is
one technique that can help to address this issue.
Atomic force microscopy (AFM) has been around since the
mid-1980s and has become a powerful research instrument in
the field of nanoscience and nanotechnology [15]. With highly
specialised instrumentation and techniques, it is even possible
to resolve molecular bonds [16,17]. Details of AFM operation
and capabilities can be found elsewhere [18,19]. However, in
brief, the AFM instrument involves a sharp probe at the end of a
cantilever interacting with a surface. Not only can the AFM be
used to visualise the surfaces of a wide range of materials
(under various environmental conditions and over a large
temperature range) the probe can also be used as a nano-
indenter to ascertain mechanical properties [20] or even to carry
out tensile testing of fibrils [21] or unfold protein molecules
[22].
In this study we have used AFM to assess two fundamental
components of skin dermis (fibroblasts and their secreted prod-
uct, collagen) following interaction with tattoo ink particles. We
examine the shape and size of tattoo ink particles on cellular
and tissue surfaces. Further, we also investigate the cell
viability of dermal fibroblasts after incubation with filtered/
unfiltered diluted tattoo ink and discuss these results in the
context of nanoparticle research.
Results and Discussion
Tattoo ink particle size distribution
Following three repeats of the particle size distribution proce-
dure, the mode (peak intensity) value was 240.9 ± 2 nm. The
same ink was also passed through a 220 nm filter to investigate
the effect of increasing the proportion of nano-particulate
pigment in the ink. Repeating the particle size analysis after
filtration, the peak mode value reduced to 151 ± 2 nm
(Figure 1a).
The light scattering technique used to make these measure-
ments cannot distinguish between primary particles, aggregates
and agglomerates. This means that the primary pigment parti-
cles may be smaller than the distribution suggests, although
they cannot be larger. However, the agglomeration behaviour of
the particles will be strongly influenced by the in vivo condi-
tions in tattooing, or the in vitro conditions in cell culture.
Agglomeration due to electrochemical processes can reduce the
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Figure 1: (a) Particle size distribution of filtered vs unfiltered commer-
cially available tattoo ink, showing data ranging between 30 to 600 nm
(filtered) and 40 to 970 nm (unfiltered). (b) Amplitude image of tattoo
ink particles showing single and agglomerated particles adhered to a
glass substrate.
effective number of particles by orders of magnitude and this
will have a profound effect on how the particles are dealt with
by cells and tissues.
AFM scanning of the tattoo ink that was adhered to the glass
slide was carried out in order to isolate and measure the
smallest particle size, as well as to explore agglomeration
behaviour. In AFM imaging, the amplitude (error) image often
gives greater clarity, as it is a more efficient edge detector and is
not low-pass filtered through the electronic feedback loops [23].
The z-scale on the amplitude images reflects changes in the
height moved by the piezo sensors to maintain the engage
amplitude setpoint. From the amplitude image in Figure 1b it
can be seen that the particles have strongly agglomerated
following the deposition process, although, a small number of
individual particles can be seen in the upper left portion of the
image. These single, non-agglomerated particles in the AFM
image (n = 16) exhibited a mean projected area of 2895 nm2,
which translates to a diameter of 60.7 nm assuming a spherical
shape. For this study we have only examined one commercially
available tattoo ink. However, the AFM and particle size distri-
bution results are in strong agreement with Høgsberg et al., who
carried out a large study of 58 tattoo inks of six different
colours [24], where 99.94% of the volume of ink was made up
from particles smaller than 100 nm.
It is clear that tattoo ink contains nanoparticles, given the peak
size of the particle distribution and the AFM imaging of the ink
on a glass slide. It remains unclear what potential toxicological
effects tattoo ink components may have on cells, collagen fibrils
etc. because of their nanometre-scale size. A gram of 60.7 nm
carbon spheres would have a surface area of about 40 m2; over
100000 times larger than the surface area of the equivalent bulk
material. In addition, materials are known to behave differently
at the nanometre-level in comparison with samples at the bulk
level.Nanoparticle surface atoms have an increased reactivity
over bulk surface atoms [9]. However, on the whole, tattoo
pigments do appear to be reasonably well tolerated by the skin,
and no clear relationship between tattoo exposure and skin
cancer (or cancers in general) has yet been established [24]. As
cancers in general can take years if not decades of toxicant
exposure to materialise, we will need to monitor how the recent
dramatic increase in large-scale tattooing may impact on (skin)
cancer rates.
Microscopy of tattoo particles in skin tissue
Using the AFM top down optical microscope it was straightfor-
ward to manipulate the skin tissue section so that the cantilever
was at the periphery of a clump of ink particles in the dermis
(Figure 2a). A number of images were taken at various loca-
tions; Figure 2b shows a typical AFM height and corres-
ponding amplitude image (Figure 2c) of a region in the upper
dermis that contains tattoo ink particles. These AFM images
clearly show the dense collagen fibril network with agglomer-
ates of tattoo ink particles. The surface topography of the
dermis is quite undulating with a surface roughness Ra of 30 nm
over the 10 μm scan region.
The collagen fibrils here have a strong degree of parallel orien-
tation, which would suggest that this region may well be scar
tissue that was formed following the tattoo process. In a recent
AFM study we compared scar tissue and healthy skin tissue and
demonstrated that greater alignment of collagen fibrils occurs in
scar tissue, as well as highlighting the reduction in the biome-
chanical performance of the scar tissue [25]. However, due to
patient confidentiality it was not possible to find out more about
how long the subject had the tattoo. Further, as the subject was
62 years old, the skin was also aged, including photo-aged from
Beilstein J. Nanotechnol. 2015, 6, 1183–1191.
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Figure 2: (a) AFM optical image (10×) showing the cantilever over a
region of tattoo ink in the dermis; scale bar 200 μm. (b) 10 μm AFM
height and (c) amplitude (error) image of cryosectioned tattooed skin.
Black arrows indicate a large agglomerate and white arrows smaller
agglomerates of tattoo ink particles.
exposure of the forearm to UV irradiation. From multiple scans
over a number of sections of tattooed skin tissue, it is clear that
there were many regions of highly agglomerated ink particles,
as shown in Figure 3. These agglomerations can be larger than
the dermal cells, thereby changing the nature of the interaction
between the pigment and the surrounding skin cells.
More detailed close-up scans (Figure 4a–d) also showed ink
particles in close proximity to collagen fibrils. In the amplitude
Figure 3: 12 μm amplitude images of highly agglomerated tattoo ink
particles in the collagen network.
images (Figure 4b and Figure 4d), the periodic banding that is
associated with collagen fibrils can clearly be resolved [26,27].
The inset of Figure 4e is a detailed view of the area surrounding
a small cluster of particles from Figure 4d, with the corres-
ponding line profile shown in Figure 4e. The pigment particle
here has a width of 37.5 nm at half height. When measuring a
spherically shaped object with a rounded AFM probe, it is
common to use the dimension at half height, to try and avoid
probe convoluted distortions [28]. This line section shows that
Beilstein J. Nanotechnol. 2015, 6, 1183–1191.
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Figure 4: Height (a & c) and amplitude (b & d) images of disperse ink particles in the dermal collagen network. (Inset of (e)) 500 nm image of small
cluster of ink particles from the solid red square (e) Line profile showing a particle of 37.5 nm width at half height.
the tattoo ink pigments are truly nanoparticles embedded in the
dermal collagenous network, which were visible especially at
the periphery of a clump of deposited particles. Wherever pri-
mary pigment particles could be resolved they were of approxi-
mately this diameter, suggesting that the observed ink particle
size distribution reflects the range of agglomeration level rather
than a wide range of primary particle sizes. It is also noted that
images of ink particles on the control glass slide are remark-
ably similar to the images of the tattoo ink in the dermis (c.f.
Figure 1b and Figure 3c).
It should be noted that these images are of surfaces, sectioned
from bulk samples. In vivo these particles would sit within a
three dimensional extracellular matrix structure where the parti-
cles do not always sit at the surface. Further, the act of
sectioning might disrupt the particles, potentially breaking up
agglomerates. However, every effort was taken to avoid this by
controlling the cryosectioning conditions and using new blades.
Even though imaging in air may lead to unknown artefacts
within the tissue, the resolution is much better. Capturing a scan
of the tissue under aqueous conditions in a non-tattoo part of the
skin section yielded images of collagen fibril networks without
particle matter, but were of lower quality (Figure 5). AFM fluid
imaging has to use a cantilever spring constant that is about two
orders of magnitude lower, which makes scanning trickier.
Also, the tissue surface becomes softer.
Beilstein J. Nanotechnol. 2015, 6, 1183–1191.
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Figure 5: 3D reconstruction of AFM image on non-tattoo portion of the
skin tissue under aqueous conditions (UHQ water).
Tattoos inevitably fade over time with a redistribution of the
pigments deeper into the dermis and some even entering dermal
blood vessels before transportation to local lymph nodes [29].
This leads one to question the extent of transportation of ink
pigment particles throughout the body from the tattooing
process. Light microscopy analysis of tattooed skin section
revealed some interesting features. Figure 6a shows a trans-
verse section of histologically stained tattooed skin, with the
epidermal region uppermost in the image. Clumps of tattoo ink
have dispersed throughout the upper and lower dermis.
However, close inspection of a deep dermal blood vessel
(Figure 6b) showed regions of tattoo ink scattered in the vessel
wall as well as inside (peri)-vascular cells. A recent study, using
a model system of mice tattooed with a commonly used ink to
investigate the transportation and photo-decomposition of tattoo
pigment particles [30], reported that the amount of ink in the
mouse skin had reduced by 32 ± 16% of its initial value 42 days
after tattooing. Furthermore, exposure of tattooed skin to simu-
lated sun light and laser light also reduced the amount of ink
particles retained in the skin [30]. A related study examined the
distribution and accumulation of micrometre- and nanometre-
sized silver particles following subcutaneous injection in rats,
and found that silver nanoparticles were distributed throughout
the main organs especially kidney, liver, spleen, brain and lungs
[31]. By contrast, the micrometre-sized silver particles did not
get into the blood circulation.
AFM imaging of dermal fibroblasts
Several studies have been conducted on fibroblasts using AFM
to visualise both their surface and nano-mechanical properties
[32-35]. Here, we show AFM images of dermal fibroblasts after
incubation in diluted tattoo ink. This gives us an opportunity to
visualise how tattoo ink particles may interact with dermal cells
replicating the first moments following tattoo ink insertion in
the skin. The AFM image of the fibroblast (Figure 7a) shows
Figure 6: Light microscopy view of stained adult human tattooed arm
skin. (a) Large deposits of dark ink particles distributed in a clumped
manner in the dermis; scale bar 75 μm. (b) A deep dermal vessel with
aggregations of ink particles in/around vessel wall and inside some
associated cells; scale bar 15 μm.
that the fixed cell is quite large, over 2 μm in height, therefore
the small ink nanoparticles are difficult to see. However, phase
imaging at a zoomed-in location on the cell surface (Figure 7b)
highlights the ink particles very well. There appears to be a
large number of ink particles attached to the cell surface in
200–500 nm clumps. However, it is not clear how much ink
may have penetrated the cell, as the AFM technique can only
probe surfaces.
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zolium bromide) assay is a commonly used biological test on
living cells, which broadly measures the in vitro cytotoxic
effects of drugs on cell lines or primary patient cells [36].
Recently, an MTT assay for cytotoxicity assessment was carried
out on fibroblasts exposed to two different diluted tattoo inks,
which showed both cell death and inhibition of pro-collagen
synthesis [37]. As that study was not carried out on skin fibro-
blasts it was decided to run a similar cell viability test using
Beilstein J. Nanotechnol. 2015, 6, 1183–1191.
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Figure 7: (a) AFM height image of a large fibroblast in vitro and incubated with diluted tattoo ink (1:10,000), followed by chemical fixation. (b) Phase
image (5 μm) of the highest part of the cell body, which shows many regions (red arrows) of clumped ink particles on the cell surface.
Figure 8: Cell viability of skin dermal fibroblasts incubated in diluted
tattoo ink for seven days (filtered and unfiltered).
human adult skin dermal fibroblast cells (the cells targeted in
skin tattooing) with both filtered and unfiltered commercially
available black ink.
The MTT assay results (shown in Figure 8) indicated that at an
ink dilution of 1:100 the dermal fibroblast viability was reduced
significantly after a one week exposure. A reduction in viability
was also noted from similar work on gingival fibroblasts
exposed to a different tattoo ink source [37]. As the MTT assay
is a colourimetry-based technique, the use of dark pigments can
be problematic. It was found that the lowest dilution of tattoo
ink for the MTT assay to work was 1 in 100. Wamer and Yin
found a phototoxic effect of eight decorative tattoo inks and
permanent make-up inks that contained titanium dioxide on
human dermal fibroblasts [38]. The phototoxic effect from the
inks was attributed to the generation of hydroxyl radicals under
UV excitation.
Interestingly, fibroblast viability was lowered to a greater extent
in filtered (and diluted 1:100) than unfiltered ink, i.e.,
17.6 ± 1.2% viability versus 38.3 ± 2.7% viability. Filtering the
ink caused larger ink particles to be removed from the suspen-
sion, reducing the overall solid content of the ink. If the cyto-
toxicity were simply due to the amount of pigment in the
culture media then filtration would be expected to reduce toxi-
city. It may be that in the culture media large particles act as
nuclei for agglomeration of the pigment, reducing the toxic
activity. Without these nucleation sites, primary nanoparticles
may remain in suspension in very large numbers, thereby
presenting the cell with a greater nanoparticle challenge and so
interference of their cell physiology.
This finding demonstrates that smaller pigment particles cause
an increase in fibroblast death over a period of one week. A
further implication of this particle size reduction may occur
during attempts to remove tattoos by using lasers during which
tattoo ink clusters are broken up into smaller and potentially
more cytotoxic particles. It is worth highlighting that the cell
incubation period of a week was used here to try and replicate
the initial conditions that fibroblasts may encounter during the
immediate to early post-tattoo period. The long-term behaviour
of the dermal fibroblasts is not likely to be damaged or hindered
and will recover following the tattoo procedure.
Conclusion
In this study we have demonstrated that a commercially avail-
able black tattoo ink contains nanoparticles and that the modal
particle size can be reduced by simple filtration. Atomic force
microscopy can be used to successfully observe nanoparticles of
tattoo ink in human skin tissue as well as on dermal fibroblasts
in vitro. A single isolated nanoparticle of tattoo ink pigment in
the region of 40 nm diameter was visualised from a dermal
Beilstein J. Nanotechnol. 2015, 6, 1183–1191.
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section of tattooed skin. The strong parallel orientation of the
collagen fibrils was also noted in the tattooed skin, which was
consistent with previous findings in wound healing/scar
tissue [25].
Fibroblasts that were incubated in diluted tattoo ink also
showed nanoparticles of ink pigments on their cell surface.
Although it was not possible to explore using AFM method-
ology whether ink pigment nanoparticles could be taken up by
the cells, this may be accomplished by ultrathin sectioning of
such cells. However, the MTT assay using 1:100 diluted tattoo
ink showed considerable fibroblast death. The amount of cell
death with filtered tattoo ink was greater than the amount of cell
death using unfiltered ink, which can be attributed to the subse-
quent reduction in tattoo ink particle size.
Experimental
Particle size distribution
The particle size distribution of the ink was determined by using
a Mastersizer 3000, (Malvern Instruments Ltd., Malvern, UK).
Tattoo ink (Scream Ink – Pitch Black, The Tattoo Shop, UK)
was diluted in ultra-pure water (1:1000), pipetted into a dispos-
able cuvette and then placed in the instrument. Detectors then
accurately measured the intensity of light scattered by the parti-
cles in the ink for red and blue light wavelengths over a range
of angles.
Tattoo skin sample
Skin samples were obtained from the forearm of a 62 year old
male. Full approval was obtained from the ethics committee of
the clinic and University for the use of this tissue in this
research. The skin samples were frozen upon arrival in the
laboratory and stored at −80 °C. Skin specimens from the
tattooed region were attached to a metal chuck using optimum
cutting temperature (OCT) embedding compound (Agar Scien-
tific, Essex, England), then sectioned in a cryostat (CM1510,
Leica Microsystems, Wetzlar, Germany ) at 5 μm thickness and
the sections collected onto polylysine-coated microscope slides.
Tissue sections for light microscopy imaging (Nikon Eclipse
80i, Japan) were stained with haematoxylin and eosin, and then
gently washed before mounting with a glass cover slip.
Skin tissue collection for isolation and culture
of dermal fibroblasts
Normal human tissue (female, 35 years of age) was sourced
from elective plastic surgery (facelift) and placed immediately
in transport media. After arrival at the laboratory the skin
samples were cleaned in wash solution (PBS containing
5 × Pen/Strep with antimycotics/antifungal (5 × PBS)) and any
fat removed. Full approval was obtained from the ethics
committee of the clinic and University for the use of this tissue.
Skin was cut into 0.5 × 1.0 cm pieces then placed in 0.1%
trypsin overnight at 4 °C. The following day tissue was incu-
bated for 1 h at 37 °C to separate epidermis from dermis. The
epidermis was removed and the remaining dermis placed upside
down in a 75 cm3 flask in RPMI 1640 medium (Invitrogen),
then placed in a 37 °C incubator containing 5% CO2. After five
days the dermis was removed and the culture maintained. Cells
were grown in RPMI 1640 supplemented with 10% fetal bovine
serum (Invitrogen), 100 μg/mL Primocin (Source Bioscience)
and 1% GlutaMAX (Invitrogen).
MTT assay
Dermal fibroblasts (passage 3) were trypsinised and seeded into
96-well plates at a density of 1 × 104 cells/well. The plates were
maintained overnight (16 h) in RPMI 1640 medium to allow for
cell attachment. The plates were incubated for 24 h in serum-
starved medium (i.e., lacking fetal bovine serum) to remove
exogenous sources of growth factors, before being exposed to
the tattoo ink. Unfiltered and 0.22 μm filtered tattoo ink was
diluted in ‘starved’ medium and added to the plate at dilutions
ranging between 1:102 and 1:106. The plates were placed in a
37 °C incubator containing 5% CO2 for 1 week, then washed
with phosphate buffer solution (PBS) and incubated with
serum-starved medium containing 0.5 mg/mL tetrazolium dye
(MTT) for 4 h. The medium was carefully removed and 150 μL
of dimethyl sulfoxide (DMSO) added to each well. The plate
was gently shaken to achieve complete dissolution of the
formazan crystals then the absorbance read on a spectropho-
tometer (Tecan Infinite) at 550 nm. The results were analysed
and presented as a percentage of the untreated control samples.
A cell plate that did not undergo the MTT procedure but did
have cells incubated with the tattoo ink was treated with
4% glutaraldehyde for 20 min in order to chemically fix the
cells for AFM analysis. Chemically fixed samples were exhaus-
tively washed and rinsed in ultra-pure water and gently dried
under a stream of nitrogen.
AFM
Separate microscope slides containing the cryo-sectioned skin
tissue samples and fixed fibroblast cells were placed on the
sample stage of the MFP-3D AFM (Asylum Research, Santa
Barbara, USA) and imaged in air in intermittent contact
mode using Olympus AC160 silicon probes (k ≈ 40N/m,
tip radius ≈  10 nm) and AC240 probes (k ≈  2N/m,
tip radius ≈ 10nm). The AFM optics (10×) were used to iden-
tify an appropriate region of interest before scanning.
Diluted tattoo ink (1:10,000) from the particle size testing was
then deposited on to a poly-L-lysine-coated glass slide for 60 s
then washed off and dried in a steady stream of nitrogen. AFM
Beilstein J. Nanotechnol. 2015, 6, 1183–1191.
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imaging was carried out to examine the tattoo ink particles that
were used in the particle size distribution testing.
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